Staging of endometrial cancer (total hysterectomy and pelvic lymph node dissection)
Conditions
Interventions
Sponsors
Peking Union Hospital, Chinese Academy of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Diagnosis of intrauterine membrane carcinoma, and preoperative diagnosis of stage I (FIGO 2009 stage) by imaging examination; (2) Endometrial carcinoma was diagnosed by curettage; (3) Aged 18-80 (inclusive); (4) Be able to cooperate and complete follow-up and related examinations; (5) Voluntarily participate in this trial and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) have a severe uncontrolled illness or acute infection; Patients with cardiovascular, cerebrovascular, immune system and diabetes mellitus who can not be controlled and can not meet the operation criteria; (3) Diagnostic curettage revealed serous carcinoma, clear cell carcinoma and carcinosarcoma; (4) Preoperative adjuvant therapy such as radiotherapy and chemotherapy; Radiographically positive pelvic or para-aortic lymph nodes;(6) Poor vaginal conditions, unable to complete uterine extraction (as assessed by the investigator); (7) There are severe pelvic and abdominal adhesions, which are not suitable for laparoscopic surgery; (Viii) participating in other clinical trials of investigational drugs or devices that have not been completed.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of unconverted surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Operation time;Intraoperative bleeding;Intraoperative blood transfusion; | — |
Countries
china
Contacts
Public ContactXiang Yang
Peking Union Hospital, Chinese Academy of Medical Sciences
Outcome results
None listed